Live Quote · NASDAQPVLAHealthcare· Biotechnology

Palvella Therapeutics, Inc.

$146.76 6.15%(+$8.50)
TickerSpark Score
63/100
Mixed
50
Valuation
20
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PVLA research report →

52-Week Range89% of range
Low
$23.76
Current
$146.76
High
$161.38
Company Overviewpalvellatx.com

About the company

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.

CEO
Wesley H. Kaupinen
IPO
2015
Employees
14
HQ
Wayne, PA, US

Price Chart

+515.86% · this period
$154.84$89.34$23.83Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.74B
P/E
-35.19
P/S
0.00
P/B
8.27
EV/EBITDA
-41.89
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
-56.87%
ROIC
-17.89%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-41,715,000 · -139.27%
EPS
$-3.71 · 52.62%
Op Income
$-38,602,000
FCF YoY
-130.68%
Performance & Tape
52W High
$161.38
52W Low
$23.76
50D MA
$120.89
200D MA
$101.39
Beta
-0.19
Avg Volume
263.13K

Get TickerSpark's AI analysis on PVLA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 29, 26Pauls Matthewother6,000
Jun 29, 26Pauls Matthewother0
Jun 17, 26Goin Kathleenother2,154
Jun 17, 26Goin Kathleenother2,148
Jun 17, 26Goin Kathleenother2,148
Jun 17, 26Goin Kathleenother2,154
Jun 17, 26Goin Kathleensell2,390
Jun 17, 26Goin Kathleensell1,887
Jun 17, 26Goin Kathleensell25
Jun 12, 26Korenberg Matthew Eother1,000
Coverage · PVLA

Our PVLA coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on PVLA yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate PVLA report →
Internal Compare

Similar companies

Peers in the same neighborhood.